Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 9761250)

Published in Clin Chem on October 01, 1998

Authors

E Schütz1, D Svinarov, M Shipkova, P D Niedmann, V W Armstrong, E Wieland, M Oellerich

Author Affiliations

1: Abteilung Klinische Chemie, Georg-August-Universität Göttingen, Germany. eschuetz@med.uni-goettingen.de

Articles by these authors

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet (1993) 2.66

The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial. Eur J Endocrinol (1997) 1.99

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85

Stereochemistry of polymerization by DNA-dependent RNA-polymerase from Escherichia coli: an investigation with a diastereomeric ATP-analogue. Proc Natl Acad Sci U S A (1976) 1.65

A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A (1989) 1.62

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Cancer Res (1999) 1.51

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation (2001) 1.51

Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. Pharmacol Res (2010) 1.50

Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. Arthritis Rheum (1997) 1.48

Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. Clin Chim Acta (1991) 1.47

Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. Am J Cardiol (1990) 1.44

Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction. Lancet (1990) 1.41

The use of lidocaine as a test of liver function in liver transplantation. Liver Transpl Surg (1996) 1.39

Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC--a multicenter evaluation. Clin Chem (1997) 1.39

Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit (2001) 1.17

Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Br J Pharmacol (1999) 1.16

Application of a thermodynamic nearest-neighbor model to estimate nucleic acid stability and optimize probe design: prediction of melting points of multiple mutations of apolipoprotein B-3500 and factor V with a hybridization probe genotyping assay on the LightCycler. Clin Chem (1999) 1.15

Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem (2000) 1.14

Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol (2001) 1.13

EXAFS study of Nd(III) uptake by amorphous calcium silicate hydrates (C-S-H). J Colloid Interface Sci (2009) 1.12

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med (1995) 1.12

Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit (2003) 1.10

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09

Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08

New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Clin Chem (2000) 1.07

No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. Clin Chem (2001) 1.07

Enzyme immunoassays in clinical chemistry: present status and trends. J Clin Chem Clin Biochem (1980) 1.04

Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand (2004) 1.02

Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01

Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis (1989) 1.01

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Ther Drug Monit (2000) 1.01

Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest (1989) 1.00

The reaction between thiols and 8-azidoadenosine derivatives. Nucleic Acids Res (1976) 1.00

Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem (1998) 0.98

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta (1991) 0.98

Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. Eur J Respir Dis (1985) 0.98

Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. J Am Soc Nephrol (1998) 0.98

Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation (1990) 0.97

Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int (1988) 0.97

Adrenergic regulation of lipolysis in abdominal adipocytes of obese subjects during caloric restriction: reversal of catecholamine action caused by relief of endogenous inhibition. Eur J Clin Invest (1985) 0.96

Determination of methotrexate in serum by a rapid, fully mechanized enzyme immunoassay (EMIT). J Clin Chem Clin Biochem (1980) 0.96

Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc (1998) 0.96

Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. Lab Invest (1999) 0.95

DNA base bulge vs unmatched end formation in probe-based diagnostic insertion/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR. Clin Chem (2000) 0.95

Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin Chem (2000) 0.94

The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit (2001) 0.94

Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics. Clin Pharmacol Ther (2009) 0.94

Modification of an essential arginine in Escherichia coli DNA-dependent RNA polymerase. FEBS Lett (1976) 0.94

Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem (1999) 0.94

Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. Clin Biochem (1998) 0.94

New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem (2001) 0.94

Mechanistic studies on deoxyribonucleic acid dependent ribonucleic acid polymerase from Escherichia coli using phosphorothioate analogues. 2. The elongation reaction. Biochemistry (1979) 0.93

Spectroscopic investigation of Ni speciation in hardened cement paste. Environ Sci Technol (2006) 0.93

Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy. Int J Cancer (1998) 0.93

Mechanistic studies on deoxyribonucleic acid dependent ribonucleic acid polymerase from Escherichia coli using phosphorothioate analogues. 1. Initiation and pyrophosphate exchange reactions. Biochemistry (1979) 0.92

Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry. J Chromatogr A (2004) 0.92

Diffusion of tritiated water and 22Na+ through non-degraded hardened cement pastes. J Contam Hydrol (2003) 0.92

Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, "two-color/shared" anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design. Clin Chem (2000) 0.92

Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit (1995) 0.92

The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin. Clin Pharmacokinet (1984) 0.91

Current view: indications for extracorporeal lipid apheresis treatment. Clin Res Cardiol Suppl (2012) 0.91

Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol (1998) 0.90

Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation. Thromb Res (2000) 0.90

Methemoglobin formation and binding to blood constituents as indicators for the formation, availability and reactivity of activated metabolites derived from trans-4-aminostilbene and related aromatic amines. Arch Toxicol (1978) 0.89

Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem (1995) 0.89

Total oxygen consumption, ketone body ratio and a special score as early indicators of irreversible liver allograft dysfunction. Transplant Proc (1989) 0.89

Use of two reporter dyes without interference in a single-tube rapid-cycle PCR: alpha(1)-antitrypsin genotyping by multiplex real-time fluorescence PCR with the LightCycler. Clin Chem (2000) 0.89

Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system. Klin Wochenschr (1987) 0.89

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite. Clin Biochem (2000) 0.88